Sign in
4

Changes in Ownership

Cocrystal Pharma, Inc. Filed Acc 0001493152-22-021149

Options or other derivatives

  • Director acquired 188,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Rubin Steven D Director 2022-07-25 Grant or award · Stock Options (Right to Buy) +188,000 188,000 D
Loading xslF345X03/ownership.xml…